Linking doctors and researchers around the world

• The RBTC collects tumor, CSF and blood and clinical data from newly diagnosed or prior patients with suspected or confirmed rare brain tumor diagnoses from global member sites
• Biomaterials are used for
  • Generation of cell lines for drug studies,
  • Genetic, molecular and histopathologic studies to investigate or confirm diagnoses
  • Genomic studies to discover nature of tumor-causing processes
• Clinical data of rare brain tumor patients including pathology reports, treatment and imaging information are linked with molecular findings and shared with the global community to
  • Improve clinical recognition and develop more specific and sensitive diagnostic assays
  • Inform new approaches or types of therapies for rare brain tumor patients